PFIZER INC Quarterly Other Assets, Current in USD from Q4 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Pfizer Inc quarterly Other Assets, Current history and growth rate from Q4 2012 to Q2 2024.
  • Pfizer Inc Other Assets, Current for the quarter ending June 30, 2024 was $4.19B, a 13.2% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.19B -$638M -13.2% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $4.37B -$748M -14.6% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $4.91B -$106M -2.11% Dec 31, 2023 10-Q 2024-08-05
Q3 2023 $4.62B -$1.53B -24.8% Oct 1, 2023 10-Q 2023-11-08
Q2 2023 $4.83B -$1.14B -19.1% Jul 2, 2023 10-Q 2023-08-09
Q1 2023 $5.12B +$918M +21.8% Apr 2, 2023 10-Q 2023-05-10
Q4 2022 $5.02B +$1.2B +31.3% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $6.15B +$2.36B +62.2% Oct 2, 2022 10-Q 2022-11-09
Q2 2022 $5.97B +$2.15B +56.4% Jul 3, 2022 10-Q 2022-08-10
Q1 2022 $4.2B +$111M +2.71% Apr 3, 2022 10-Q 2022-05-11
Q4 2021 $3.82B +$174M +4.77% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $3.79B +$1.27B +50.5% Oct 3, 2021 10-Q 2021-11-12
Q2 2021 $3.82B +$1.31B +51.9% Jul 4, 2021 10-Q 2021-08-12
Q1 2021 $4.09B +$1.35B +49.5% Apr 4, 2021 10-Q 2021-05-13
Q4 2020 $3.65B +$1.29B +54.7% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $2.52B -$435M -14.7% Sep 27, 2020 10-Q 2020-11-05
Q2 2020 $2.51B -$22M -0.87% Jun 28, 2020 10-Q 2020-08-06
Q1 2020 $2.74B +$170M +6.62% Mar 29, 2020 10-Q 2020-05-07
Q4 2019 $2.36B -$104M -4.23% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $2.95B +$504M +20.6% Sep 29, 2019 10-Q 2019-11-07
Q2 2019 $2.54B +$192M +8.2% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $2.57B +$441M +20.7% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $2.46B +$172M +7.51% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $2.45B +$292M +13.5% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $2.34B +$466M +24.8% Jul 1, 2018 10-Q 2018-08-09
Q1 2018 $2.13B -$92M -4.15% Apr 1, 2018 10-Q 2018-05-10
Q4 2017 $2.29B +$40M +1.78% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $2.16B -$685M -24.1% Oct 1, 2017 10-Q 2017-11-09
Q2 2017 $1.88B -$1.15B -37.9% Jul 2, 2017 10-Q 2017-08-10
Q1 2017 $2.22B -$137M -5.82% Apr 2, 2017 10-Q 2017-05-11
Q4 2016 $2.25B +$95M +4.41% Dec 31, 2016 10-K 2018-02-22
Q3 2016 $2.84B +$595M +26.5% Oct 2, 2016 10-Q 2016-11-10
Q2 2016 $3.02B +$574M +23.4% Jul 3, 2016 10-Q 2016-08-11
Q1 2016 $2.36B -$460M -16.3% Apr 3, 2016 10-Q 2016-05-12
Q4 2015 $2.15B -$689M -24.2% Dec 31, 2015 10-K 2017-02-23
Q3 2015 $2.25B -$297M -11.7% Sep 27, 2015 10-Q 2015-11-05
Q2 2015 $2.45B -$278M -10.2% Jun 28, 2015 10-Q 2015-08-06
Q1 2015 $2.82B -$658M -18.9% Mar 29, 2015 10-Q 2015-05-07
Q4 2014 $2.84B -$846M -22.9% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $2.55B Sep 28, 2014 10-Q 2014-11-06
Q2 2014 $2.73B Jun 29, 2014 10-Q 2014-08-07
Q1 2014 $3.47B Mar 30, 2014 10-Q 2014-05-08
Q4 2013 $3.69B +$122M +3.42% Dec 31, 2013 10-K 2015-02-27
Q4 2012 $3.57B Dec 31, 2012 10-K 2014-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.